DAL82 Antibody

What is DAL82 and what are its primary functions in cellular biology?

DAL82 (also known as Dal82p) is a transcriptional regulator protein in Saccharomyces cerevisiae that plays a crucial role in allophanate-induced gene expression. It functions as a positive regulator in the Notch signaling pathway. The protein binds specifically to a cis-acting element called UIS ALL (a dodecanucleotide sequence) to mediate transcriptional responses . When studying DAL82, researchers should consider its nuclear localization and its movement patterns that parallel DNA throughout the cell cycle. This protein contains multiple functional domains that contribute to its regulatory activities, including a DNA binding domain, a transcriptional activation domain, and a C-terminal region with a predicted coiled-coil motif that functions as a down-regulatory element .

How should researchers approach DAL82 protein detection and localization studies?

For effective DAL82 protein detection and localization, researchers should implement a multi-method approach. GFP-fusion constructs have proven effective for tracking DAL82 localization in live cells, as demonstrated by studies using ADH1-GFPDAL82 constructs (pSS423-82) . When designing GFP-fusion experiments, ensure the fusion does not disrupt critical protein domains. For complementary methods, consider immunofluorescence using specific antibodies against DAL82 for fixed samples. Western blotting provides quantitative expression data using epitope-tagged versions, such as the 9-amino acid influenza hemagglutinin (HA) epitope fusion demonstrated in previous studies . When interpreting localization data, always compare GFP-fusion protein functionality with wild-type protein to confirm normal activity is maintained.

What are the recommended methods for purifying DAL82 protein for in vitro studies?

For optimal DAL82 protein purification, researchers should implement a strategy that preserves protein function while achieving high purity. Based on published methodologies, expression in E. coli strain BL21(DE3) has been successful for DAL82 constructs with HA epitope tags . A multi-step purification protocol is recommended, beginning with affinity chromatography (leveraging epitope tags), followed by ion exchange chromatography to remove contaminants. When designing expression constructs, consider incorporating a Factor Xa recognition sequence to allow tag removal post-purification, as implemented in previous research models (pRD4 constructs) . Critical parameters to monitor include protein solubility, proper folding, and retention of DNA-binding activity, which can be verified through electrophoretic mobility shift assays (EMSAs). Store purified protein in appropriate buffer conditions with glycerol at -70°C to maintain functionality for downstream applications.

How can researchers effectively validate antibodies against DAL82 protein?

Validating antibodies against DAL82 requires a multi-step approach to ensure specificity and sensitivity. Begin with Western blot analysis using recombinant protein and extracts from wild-type and DAL82 deletion strains (such as SS400 or SS200) . Optimal antibody dilutions should be determined empirically for each application, as noted in general antibody protocols . For immunoprecipitation validation, cross-reference with tagged versions of the protein (such as the HA-tagged constructs described in previous studies) . To confirm antibody specificity for immunofluorescence, compare localization patterns with GFP-fusion data, which has demonstrated nuclear localization for DAL82 . When troubleshooting inconsistent results, consider epitope accessibility issues or post-translational modifications that might affect antibody recognition. Always include appropriate controls including DAL82 knockout strains (like the dal82 disruption strain SS200) to confirm signal specificity .

What strategies can researchers employ for functional domain mapping of DAL82?

For comprehensive functional domain mapping of DAL82, implement a systematic deletion analysis strategy similar to established methods in the literature. Create a series of deletion constructs targeting specific regions of the protein, as demonstrated in previous studies that identified three key functional domains . The amino acid residues 1-85 have been shown sufficient for DNA binding, while the activation domain consists of a core region (residues 66-99) plus flanking sequences . When designing deletion constructs, consider using site-directed mutagenesis for precise removal of specific residues rather than larger domain deletions for more refined analysis. A comprehensive approach should include:

• DNA binding assays (EMSAs) with various deletion constructs

• Transcriptional activation assessment using reporter systems

• Protein-protein interaction studies to identify cofactor binding regions

• Localization studies with GFP-fusion proteins containing domain deletions

The following table summarizes key functional domains based on published deletion analyses:

When interpreting results, correlate domain function with predicted structural elements and evolutionary conservation across related proteins .

How can researchers design effective experiments to study DAL82-DNA interactions?

To study DAL82-DNA interactions effectively, researchers should employ multiple complementary techniques. Electrophoretic mobility shift assays (EMSAs) have proven valuable for analyzing the binding of DAL82 to UIS ALL sequences, as demonstrated with purified recombinant protein expressed in E. coli BL21(DE3) . When designing EMSA experiments, use both wild-type and mutated UIS ALL sequences to determine binding specificity. For more quantitative measurements, consider fluorescence anisotropy or surface plasmon resonance to determine binding kinetics and affinity constants.

To identify the minimal DNA binding domain, leverage the deletion analysis approach that successfully identified residues 1-85 as sufficient for DNA binding . Complementary in vivo approaches should include:

• Chromatin immunoprecipitation (ChIP) to identify genomic binding sites

• Reporter gene assays to correlate binding with transcriptional outcomes

• DNA footprinting to precisely map the protected regions

When analyzing DNA-protein complexes, consider the potential impact of cofactors by comparing binding patterns in nuclear extracts versus purified recombinant protein. For challenging DNA sequences, optimize binding buffer conditions (salt concentration, pH, and presence of non-specific competitors) to enhance specificity .

What are the critical considerations when generating and characterizing DAL82 mutants?

Key considerations include:

• Confirming mutation through DNA sequencing

• Verifying protein expression levels by Western blot

• Assessing protein stability and half-life

• Evaluating subcellular localization compared to wild-type protein

• Testing functional outputs through appropriate reporter assays

When introducing mutations affecting specific domains (such as the essential core region of amino acids 66-99), researchers should design multiple mutants with varying degrees of alteration rather than complete deletion to distinguish between structural and functional defects . For complementation studies, express mutants from plasmids like pSS20 under control of the native promoter to ensure physiological expression levels .

A systematic approach to characterizing mutations should include:

What methodological approaches can reveal the mechanisms of DAL82-mediated transcriptional activation?

To elucidate DAL82-mediated transcriptional activation mechanisms, researchers should implement a comprehensive experimental strategy. LexA-tethering experiments have successfully demonstrated that DAL82 can mediate transcriptional activation independent of its DNA-binding domain . When setting up such systems, use constructs like lexA-DAL82 p8202 or pSS82BTM with reporter plasmids like pSH18-34 . To dissect the activation domain, create a series of internal deletions spanning the core activation region (amino acids 66-99) and flanking regions, as demonstrated in the pRD476-pRD482 series .

For mechanistic insights, researchers should investigate:

• Cofactor recruitment using protein-protein interaction assays

• Chromatin remodeling at target promoters through ChIP for histone modifications

• Mediator complex recruitment via co-immunoprecipitation studies

• Transcription initiation complex assembly using in vitro transcription systems

The coiled-coil motif in the C-terminus may function in protein-protein interactions and down-regulation of transcriptional activation . To test this hypothesis, perform targeted mutagenesis of key residues in this motif followed by activation assays. Additionally, perform RNA-seq analysis comparing wild-type and mutant strains to identify the complete regulon under DAL82 control, providing context for mechanistic studies .

How can researchers optimize GFP-fusion constructs for studying DAL82 localization and dynamics?

To optimize GFP-fusion constructs for studying DAL82 localization and dynamics, researchers should carefully consider construct design, expression control, and imaging parameters. Previous studies successfully utilized ADH1-GFPDAL82 constructs (pSS423-82) to demonstrate nuclear localization . When designing new fusion constructs, consider both N-terminal and C-terminal GFP fusions to determine which best preserves protein function. The cloning strategy used for pNVS82, incorporating fragments from pSS82BTM and pMO8, provides a template for effective construct generation .

For expression control, evaluate different promoters (constitutive vs. inducible) based on experimental needs:

• ADH1 promoter for consistent moderate expression

• GAL1 promoter for inducible expression

• Native DAL82 promoter for physiological expression levels

To capture dynamic properties, implement live-cell imaging techniques with minimal phototoxicity. Time-lapse microscopy can reveal DAL82 movement patterns that parallel DNA throughout the cell cycle . For photobleaching studies (FRAP/FLIP), optimize laser intensity and exposure times to prevent artifactual results.

Consider these advanced applications:

• Multi-color imaging with markers for nuclear envelope or chromosomes

• Super-resolution microscopy for detailed subnuclear localization

• Bimolecular fluorescence complementation (BiFC) to visualize protein interactions in vivo

When analyzing results, quantify nuclear/cytoplasmic distribution ratios and correlate with cell cycle stages. Control experiments should include free GFP expression and fusion to known nuclear and cytoplasmic proteins to validate localization patterns .

What are the best experimental approaches for investigating DAL82 interaction with the Notch signaling pathway?

For investigating DAL82 interaction with the Notch signaling pathway, researchers should implement a multi-faceted approach combining genetic, biochemical, and computational methods. While DAL82 has been identified as a negative regulator in the Notch pathway , detailed molecular mechanisms remain to be fully elucidated. Begin with epistasis analysis using yeast strains with mutations in both DAL82 and key Notch pathway components to establish genetic relationships. For protein interaction studies, co-immunoprecipitation assays with tagged versions of DAL82 and Notch pathway proteins can identify direct binding partners.

To identify regulatory targets shared between DAL82 and Notch pathway components, perform ChIP-seq analysis followed by bioinformatic comparison of binding profiles. When analyzing potential interactions, consider these key aspects:

• Competitive binding to shared DNA elements

• Protein complex formation affecting transcriptional outcomes

• Post-translational modifications influencing protein activity

• Subcellular localization changes under different conditions

For pathway modulation studies, combine overexpression and knockdown approaches with transcriptional readouts of Notch target genes. When designing experiments, include both gain-of-function and loss-of-function for both DAL82 and key Notch components to fully map regulatory relationships .

How can researchers effectively compare results from different DAL82 detection methods to resolve contradictory findings?

To resolve discrepancies, implement the following strategy:

• Validate all antibodies using Western blot against recombinant protein and extracts from wild-type and knockout strains

• Compare results from native antibodies with epitope-tagged versions

• Evaluate whether detection differences correlate with experimental conditions

• Test multiple fixation and extraction methods for immunofluorescence studies

• Consider protein conformational changes that might mask epitopes

A comprehensive comparative analysis should include:

When reporting results, clearly document methodological details that might influence detection, including buffer compositions, antibody concentrations, incubation conditions, and image acquisition parameters .

What considerations are important when designing ELISA systems for DAL82 protein detection?

When designing ELISA systems for DAL82 protein detection, researchers should carefully consider antibody selection, assay optimization, and validation strategies. While direct examples of DAL82-specific ELISAs are not detailed in the provided materials, principles from related antibody-based detection systems can be applied . Begin by developing or acquiring two antibodies recognizing different, non-overlapping epitopes of DAL82 for sandwich ELISA development.

Critical considerations include:

• Antibody pair compatibility (ensuring no steric hindrance)

• Optimal coating concentrations for capture antibody

• Blocking conditions to minimize background

• Sample preparation methods to release DAL82 from nuclear compartments

• Detection system sensitivity (colorimetric vs. chemiluminescent)

For assay optimization, perform checkerboard titrations of both capture and detection antibodies to determine optimal concentrations. The standard curve development approach described for DLK2/EGFL9 ELISA, with serial dilutions of recombinant protein, provides a useful template . When generating recombinant DAL82 for standards, consider using the expression system described for E. coli BL21(DE3) with appropriate purification steps .

Validation should include:

• Specificity testing with DAL82 knockout samples

• Spike-and-recovery experiments to assess matrix effects

• Dilutional linearity to confirm proportional detection

• Intra- and inter-assay coefficient of variation measurements

For challenging samples, consider including detergents and nuclear extraction buffers in sample preparation protocols to ensure complete release of nuclear-localized DAL82 .